Cerevel Therapeutics’ Parkinson’s disease therapy tavapadon has shown efficacy in a phase 3 trial, reinforcing its blockbuster potential and no doubt delighting AbbVie, which has agreed to buy the ...

Britain's media regulator launched an investigation into Elon Musk's X on Monday over concerns its Grok AI chatbot was creating sexually intimate deepfake images in violation of its duty to protect ...